Funding Briefs

Following Through For Children The Thrasher Research Fund of Salt Lake City, Utah, is preparing to launch a program to strengthen its ongoing interest in research on childhood diseases. This fail the fund will begin a program to encourage organizations to implement discoveries made in the laboratory. The fund hopes to devote about 25% of its more than $1 million annual expenditures to this effort. The fund, which was launched by California inventor E.W. Thrasher, is affiliated with the Mormon

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The Thrasher Research Fund of Salt Lake City, Utah, is preparing to launch a program to strengthen its ongoing interest in research on childhood diseases. This fail the fund will begin a program to encourage organizations to implement discoveries made in the laboratory. The fund hopes to devote about 25% of its more than $1 million annual expenditures to this effort. The fund, which was launched by California inventor E.W. Thrasher, is affiliated with the Mormon Church and focuses on research relating to nutritional deficiencies and microbiology. It does not support studies in the area of reproductive physiology. For more information, write The Thrasher Research Fund, 50 East North Temple St., 7th floor, Salt Lake City, Utah 84150, or call (801) 240-3386.

The Robert J. and Helen C. Kleberg Foundation of San Antonio, Texas, which spends nearly $3 million annually on medical research, has an unusually open policy toward applicants. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies